Literature DB >> 32925595

Mycoplasma genitalium and Bacterial Vaginosis-Associated Bacteria in a Non-Clinic-Based Sample of African American Women.

Kristen R Moore1, Meena Tomar2, Brandie D Taylor3, Scott E Gygax, David W Hilbert, Donna D Baird1.   

Abstract

BACKGROUND: Mycoplasma genitalium is associated with adverse reproductive problems. However, prevalence estimates from studies that screen women not seeking care are rare. Studies have reported co-occurrence of M. genitalium with bacterial vaginosis (BV), but no prior study of specific BV-associated bacteria has been conducted in African Americans whose reproductive tract infection burden is high.
METHODS: Using quantitative polymerase chain reaction, we screened vaginal swabs for M. genitalium, 9 BV-associated bacteria, and 4 Lactobacillus species from 200 participants drawn from a cohort of African Americans 23 to 35 years old. Sexual history, herpes serostatus, and Nugent score had been assessed. Prevalence of M. genitalium was computed. The associations of other vaginal bacteria with M. genitalium were examined with binomial regression.
RESULTS: M. genitalium prevalence was 18%. Detection and quantity of 2 BV-associated bacteria were significantly associated with a higher prevalence of M. genitalium (Leptotrichia/Sneathia: detection prevalence ratio (PR) of 2.9 [95% confidence interval {CI}, 1.1-7.7] and quantity PR of 1.2 [95% CI, 1.0-1.3]; Megasphaera phylotype 1: detection PR of 2.2 [95% CI, 1.2-4.2] and quantity PR of 1.1 [95% CI, 1.0-1.2]). Increased quantity of L. iners was also positively associated with M. genitalium (PR, 1.3 [95% CI, 1.0-1.8]). Nugent ≥7, herpes serostatus, and lifetime number of sex partners were not associated with M. genitalium.
CONCLUSIONS: Specific BV-associated microbes and L. iners were associated with M. genitalium, but Nugent ≥7 was not. Studies are needed to confirm a high prevalence of M. genitalium in African Americans and to understand its interactions with other vaginal bacteria.
Copyright © 2020 American Sexually Transmitted Diseases Association. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 32925595      PMCID: PMC7855098          DOI: 10.1097/OLQ.0000000000001275

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   3.868


  28 in total

1.  The association of Mycoplasma hominis, Ureaplasma urealyticum and Mycoplasma genitalium with bacterial vaginosis: observations on heterosexual women and their male partners.

Authors:  F E Keane; B J Thomas; C B Gilroy; A Renton; D Taylor-Robinson
Journal:  Int J STD AIDS       Date:  2000-06       Impact factor: 1.359

2.  Risk factors for Mycoplasma genitalium endometritis and incident infection: a secondary data analysis of the T cell Response Against Chlamydia (TRAC) Study.

Authors:  Brandie D Taylor; Xiaojing Zheng; Catherine M O'Connell; Harold C Wiesenfeld; Sharon L Hillier; Toni Darville
Journal:  Sex Transm Infect       Date:  2018-03-21       Impact factor: 3.519

3.  Mucopurulent cervicitis and Mycoplasma genitalium.

Authors:  Lisa E Manhart; Cathy W Critchlow; King K Holmes; Susan M Dutro; David A Eschenbach; Claire E Stevens; Patricia A Totten
Journal:  J Infect Dis       Date:  2003-01-29       Impact factor: 5.226

Review 4.  Social context, sexual networks, and racial disparities in rates of sexually transmitted infections.

Authors:  Adaora A Adimora; Victor J Schoenbach
Journal:  J Infect Dis       Date:  2005-02-01       Impact factor: 5.226

Review 5.  Interpreting the epidemiology and natural history of bacterial vaginosis: are we still confused?

Authors:  Jeanne M Marrazzo
Journal:  Anaerobe       Date:  2011-04-16       Impact factor: 3.331

6.  The vaginal microbiota and its association with human papillomavirus, Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium infections: a systematic review and meta-analysis.

Authors:  J Tamarelle; A C M Thiébaut; B de Barbeyrac; C Bébéar; J Ravel; E Delarocque-Astagneau
Journal:  Clin Microbiol Infect       Date:  2018-05-03       Impact factor: 8.067

7.  High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence.

Authors:  Catriona S Bradshaw; Anna N Morton; Jane Hocking; Suzanne M Garland; Margaret B Morris; Lorna M Moss; Leonie B Horvath; Irene Kuzevska; Christopher K Fairley
Journal:  J Infect Dis       Date:  2006-04-26       Impact factor: 5.226

8.  Is Mycoplasma genitalium in women the "New Chlamydia?" A community-based prospective cohort study.

Authors:  Pippa Oakeshott; Adamma Aghaizu; Phillip Hay; Fiona Reid; Sally Kerry; Helen Atherton; Ian Simms; David Taylor-Robinson; Birthe Dohn; Jorgen S Jensen
Journal:  Clin Infect Dis       Date:  2010-10-13       Impact factor: 9.079

Review 9.  Mycoplasma genitalium: an emerging cause of sexually transmitted disease in women.

Authors:  Chris L McGowin; Colin Anderson-Smits
Journal:  PLoS Pathog       Date:  2011-05-26       Impact factor: 6.823

10.  Prevalent and incident bacterial vaginosis are associated with sexual and contraceptive behaviours in young Australian women.

Authors:  Catriona S Bradshaw; Jennifer Walker; Christopher K Fairley; Marcus Y Chen; Sepehr N Tabrizi; Basil Donovan; John M Kaldor; Kathryn McNamee; Eve Urban; Sandra Walker; Marian Currie; Hudson Birden; Francis Bowden; Suzanne Garland; Marie Pirotta; Lyle Gurrin; Jane S Hocking
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.